Filter
1504
Filtered Results: 1504
Text search:
Africa
CDC:
Centres
for
Disease
Control
and
Prevention
Featured
Recommendations
192
New Publications
393
Language
Document type
No document type
798
Guidelines
215
Studies & Reports
188
Manuals
81
Fact sheets
79
Strategic & Response Plan
61
Training Material
32
Infographics
17
Brochures
15
Situation Updates
12
Resource Platforms
6
Countries / Regions
Africa
115
West and Central Africa
87
Sierra Leone
70
East and Southern Africa
65
Middle East and North Africa
64
Liberia
62
Nigeria
51
Ethiopia
46
Kenya
46
Global
42
South Africa
40
Mozambique
37
Uganda
34
Guinea
32
Rwanda
29
South Sudan
28
Tanzania
28
Angola
27
Zambia
26
Malawi
24
Yemen
23
Senegal
21
Guinea-Bissau
21
Ghana
21
Namibia
21
Syria
20
Congo, Democratic Republic of
17
Zimbabwe
16
India
11
Madagascar
11
Western and Central Europe
11
Burkina Faso
10
Germany
9
Lesotho
9
Côte d’Ivoire / Ivory Coast
8
Nepal
8
Botswana
8
Eswatini/ Swaziland
7
Latin America and the Carribbean
7
Asia
7
Mali
6
Cameroon
6
Brazil
6
Eastern Europe
6
Russia
6
Bangladesh
5
Ukraine
5
USA
4
Pakistan
4
Benin
4
Central African Republic
4
Vietnam
4
Saudi Arabia
3
Niger
3
Togo
3
Philippines
3
Somalia
3
Chad
3
Iraq
2
Afghanistan
2
Egypt
2
Thailand
2
Gambia
2
China
2
Indonesia
2
Sudan
2
South–East Asia Region
2
Western Pacific Region
2
France
2
Tunisia
2
Portugal
2
Morocco
1
Haiti
1
Jordan
1
Lebanon
1
Turkey
1
Cambodia
1
Malaysia
1
Argentina
1
Burundi
1
Cape Verde
1
Eastern Europe and Central Asia
1
Paraguay
1
Venezuela
1
Djibouti
1
Southern Africa
1
Qatar
1
North America
1
Gabon
1
Japan
1
Mauritius
1
United Kingdom
1
Spain
1
South Korea
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
619
Clinical Guidelines
125
Public Health
72
Key Resources
69
Women & Child Health
50
Capacity Building
29
Pharmacy & Technologies
25
Toolboxes
COVID-19
307
HIV
149
Ebola
142
Rapid Response
102
TB
101
AMR
61
Zika
30
Mental Health
30
Planetary Health
24
NTDs
19
Caregiver
18
NCDs
18
Polio
15
Cholera
12
Refugee
12
Pharmacy
12
Health Financing Toolbox
10
Global Health Education
8
Disability
7
Natural Hazards
5
Specific Hazards
5
Conflict
4
Social Ethics
1
This document draws on scientific evidence from the COVID-19 pandemic and from prior public health research on behaviour change, with the purpose of empowering African Union Member States to promote widespread adoption of masks in the general popula...
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID...
This guidance document addresses how physical distancing (referred to in previous guidance documents as ‘social distancing’) can help slow down transmission.
Accessed: 01.04.2020
ASLM in collaboration with the Africa Centres for Disease ... and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to provide general technical guidance to African Union Members States on the rollout, establishment, implementation, monitoring, and evaluation of SARS-CoV-2 Ag RDT interventions so as to effectively and efficiently detect, control and minimise errors in the performance of COVID-19 laboratory testing processes. It describes the core components for quality assurance, resources mobilisation and advocacy for scale up, monitoring, evaluation, learning and accountability for SARS-CoV-2 implementation.
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control ... accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
This guidance provides considerations and a series of options that can be used to inform country strategies in managing any shortages of personal protective equipment.Re-use and reprocessing of sing...
Key findings from a February 2021 survey from the Partnership for Evidence-Based Response to COVID-19 (PERC)
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control ... accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
Accessed: 31.03.2020
Ces orientations vous proposent les principes et procédures de base en matière de décontamination de l'environnement physique dans le contexte de la pandémie du coronavirus 2019 (COVID-19). La contamination des surfaces et les risques de transmission des maladies diffèrent ...
La prise en charge de la COVID-19. Programme d'enseignement pour les agents de santé communautaires
recommended
Compte tenu des lacunes en matière d'infrastructures et de ressources, il convient d'envisager de recourir à la technologie pour la gestion à distance des soins de santé dispensés aux patients pendant cette période. Comme on peut le constater, même les pays disposant d'infrastructures et de r...
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la ... et le traitement de la COVID-19 par le public dans les États membres de l’Union africaine. Actuellement, il n’y a : 1. Aucune preuve scientifique provenant d’études précliniques sur l’effet thérapeutique de l’ivermectine pour le traitement de COVID-19 2. Aucune preuve de son efficacité clinique pour la prise en charge de patients présentant une COVID-19 asymptomatique, légère, modérée ou sévère 3. Aucune donnée de sécurité concernant l’utilisation de l’ivermectine pour la COVID-19 dans la majorité des études publié
Accessed: 31.03.2020
Accessed: 02.04.2020
Accessed: 02.04.2020
